Discover and read the best of Twitter Threads about #EMAPresser
Most recents (6)
EMA's last regular press briefing on #PublicHealth emergencies twitter.com/i/broadcasts/1…
Watch live 🔴
We are now starting our final regular press briefing on EMA’s response to #COVID19 pandemic and other public health emergencies. Don’t miss our tweets during the press briefing.
Follow #EMAPresser.
🧵
We are now starting our final regular press briefing on EMA’s response to #COVID19 pandemic and other public health emergencies. Don’t miss our tweets during the press briefing.
Follow #EMAPresser.
🧵
During the pandemic media have helped us maintain trust in our work. Through their questions about #Covid19vaccines and #science, their follow-up of citizens' concerns, the public was kept informed about the approval process and the role of the medicines regulator. #EMAPresser
EMA's regular Press Briefings twitter.com/i/broadcasts/1…
According to @ECDC_EU, a new wave is expected in the coming weeks, due to new #Omicron subvariants
❗️The pandemic is not yet over.
We urge citizens to get vaccinated now, especially if your health situation puts you at higher risk of severe #COVID19. #EMAPresser
❗️The pandemic is not yet over.
We urge citizens to get vaccinated now, especially if your health situation puts you at higher risk of severe #COVID19. #EMAPresser
We are carefully following the new virus sub-variants. The virus is faster than we can ever be in adapting vaccines!
We should only consider adapting vaccines when the difference between strains in circulation and vaccines composition becomes major. #EMAPresser #COVID19
We should only consider adapting vaccines when the difference between strains in circulation and vaccines composition becomes major. #EMAPresser #COVID19
EMA Press Briefing on COVID-19 related activities, 5 May 2022 twitter.com/i/broadcasts/1…
#COVID19 infections are still in the millions worldwide. This pandemic is far from over. COVID-19 will continue to impact our lives. #EMAPresser #pandemic
Vaccines are a central pillar of the response to the #pandemic. Nearly half a million lives among people 60 years of age and older have been saved in Europe thanks to #vaccination. #COVID19 #EMAPresser
‼️ EMA’s regular press briefing on #COVID19 vaccines and treatments will be broadcast live 🔴 today, 18 January, from 16:00 to 16:30 CET. #EMAPresser
👉ema.europa.eu/en/events/ema-…
👉ema.europa.eu/en/events/ema-…
Watch live 🔴
We are now starting our regular press briefing on #COVID19 vaccines and treatments.
Don’t miss our tweets during the press briefing. Follow #EMAPresser.
👉 ema.europa.eu/en/events/ema-…
We are now starting our regular press briefing on #COVID19 vaccines and treatments.
Don’t miss our tweets during the press briefing. Follow #EMAPresser.
👉 ema.europa.eu/en/events/ema-…
Omicron & other variants: Global regulators agreed that the administration of multiple booster doses at short intervals would not be sustainable in the long term. #COVID19 #EMAPresser #ICMRA
‼️ EMA’s regular press briefing on #COVID19vaccines and treatments will be broadcast live 🔴 today, 5 October, from 14:00 to 14:30 CEST. #EMAPresser
👉ema.europa.eu/en/events/ema-…
👉ema.europa.eu/en/events/ema-…
Watch live 🔴
We are now starting our regular press briefing on #COVID19 vaccines and treatments. ema.europa.eu/en/events/ema-…
Don’t miss our tweets during the press briefing. Follow #EMAPresser.
We are now starting our regular press briefing on #COVID19 vaccines and treatments. ema.europa.eu/en/events/ema-…
Don’t miss our tweets during the press briefing. Follow #EMAPresser.
EMA concluded that 3rd doses of #Comirnaty and #Spikevax may be given to people with severely weakened immune systems aged 12 or older, at least 28 days after their second dose. #EMAPresser
Watch live 🔴
We are now starting our regular press briefing on #COVID19 vaccines and treatments.
Don’t miss our tweets during the press briefing. Follow #EMAPresser.
👉ema.europa.eu/en/events/ema-…
We are now starting our regular press briefing on #COVID19 vaccines and treatments.
Don’t miss our tweets during the press briefing. Follow #EMAPresser.
👉ema.europa.eu/en/events/ema-…
Currently approved #COVID19vaccines protect from the most acute consequence of this disease: hospitalisation and death. As many people as possible should be fully vaccinated. #EMAPresser
The evidence is becoming clearer on the need to consider additional vaccine doses for people who may poorly respond to #COVID19 vaccination, such as those with severely weakened immune systems or some elderly patients. #EMAPresser
